88 related articles for article (PubMed ID: 3217915)
1. Interaction of thrombin and factor Xa with bovine vascular endothelial cells, smooth muscle cells and rat hepatoma cells.
Dryjski M; Kuo BS; Bjornsson TD
Thromb Haemost; 1988 Oct; 60(2):148-52. PubMed ID: 3217915
[TBL] [Abstract][Full Text] [Related]
2. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.
Herbert J; Bono F; Herault J; Avril C; Dol F; Mares A; Schaeffer P
J Clin Invest; 1998 Mar; 101(5):993-1000. PubMed ID: 9486969
[TBL] [Abstract][Full Text] [Related]
3. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
[TBL] [Abstract][Full Text] [Related]
4. Antithrombin III, the major modulator of intravascular coagulation, is synthesized by human endothelial cells.
Chan TK; Chan V
Thromb Haemost; 1981 Aug; 46(2):504-6. PubMed ID: 7302889
[TBL] [Abstract][Full Text] [Related]
5. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
Elgue G; Blombäck M; Olsson P; Riesenfeld J
Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical vein endothelial cells express high affinity receptors for factor Xa.
Bono F; Herault JP; Avril C; Schaeffer P; Lormeau JC; Herbert JM
J Cell Physiol; 1997 Jul; 172(1):36-43. PubMed ID: 9207923
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of anticoagulation by covalently immobilized heparin.
Miura Y; Aoyagi S; Kusada Y; Miyamoto K
J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
Tran TH; Bondeli C; Marbet GA; Duckert F
Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of thrombin by the aortic endothelium.
Swedenborg J; Dryjski M; Olsson P
Thromb Haemost; 1983 Oct; 50(3):635-8. PubMed ID: 6648887
[TBL] [Abstract][Full Text] [Related]
10. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide.
Wang J; Morita I; Onodera M; Murota SI
J Cell Physiol; 2002 Feb; 190(2):238-50. PubMed ID: 11807828
[TBL] [Abstract][Full Text] [Related]
11. Uptake and inactivation of thrombin on rabbit aortic endothelium studied with two different substrates.
Swedenborg J; Dryjski M; Frebelius S; Olsson P
Thromb Haemost; 1985 Dec; 54(4):828-32. PubMed ID: 4089816
[TBL] [Abstract][Full Text] [Related]
12. The vascular endothelium as an inhibitor of thrombin.
Dryjski M; Olsson P; Swedenborg J
Thromb Res; 1983; Suppl 5():67-72. PubMed ID: 6612674
[TBL] [Abstract][Full Text] [Related]
13. Are factor Xa inhibitors superior to thrombin inhibitors in anticoagulation?
Stürzebecher J; Stürzebecher U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):152-6. PubMed ID: 2459011
[TBL] [Abstract][Full Text] [Related]
14. Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells.
Bretschneider E; Braun M; Fischer A; Wittpoth M; Glusa E; Schrör K
Thromb Haemost; 2000 Sep; 84(3):499-505. PubMed ID: 11019978
[TBL] [Abstract][Full Text] [Related]
15. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro.
Donnelly KM; Bromberg ME; Milstone A; Madison McNiff JM; Terwilliger G; Konigsberg WH; Cappello M
Thromb Haemost; 1998 May; 79(5):1041-7. PubMed ID: 9609244
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant activity of enzymatically synthesized amylose derivatives containing carboxy or sulfonate groups.
Takahara J; Hosoya K; Sunako M; Hirohara S; Terada K; Ando T; Tanihara M
Acta Biomater; 2010 Aug; 6(8):3138-45. PubMed ID: 20206721
[TBL] [Abstract][Full Text] [Related]
17. The role of endothelium in factor Xa regulation: the effect of plasma proteinase inhibitors and hirudin.
Friedberg RC; Hagen PO; Pizzo SV
Blood; 1988 May; 71(5):1321-8. PubMed ID: 3162814
[TBL] [Abstract][Full Text] [Related]
18. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells.
Senden NH; Jeunhomme TM; Heemskerk JW; Wagenvoord R; van't Veer C; Hemker HC; Buurman WA
J Immunol; 1998 Oct; 161(8):4318-24. PubMed ID: 9780208
[TBL] [Abstract][Full Text] [Related]
19. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
20. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
Cofrancesco E; Vigo A; Pogliani EM
Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
